TAILSTORM HEALTH INC recalls Lidocaine HCL Injection, USP 2% 200mg/10mL (20mg/mL) and EPINEPHRINE HCl 1:200,000, 10 ml Single Dose Vial, Rx only, Com
Recalled July 17, 2024 · FDA recall D-0594-2024 · TAILSTORM HEALTH
Hazard
Subpotent Drug: reduced efficacy for epinephrine · FDA Class II
Units
12,525 10 mL vials
Sold at
Nationwide in the USA
Description
Subpotent Drug: reduced efficacy for epinephrine
Product
Lidocaine HCL Injection, USP 2% 200mg/10mL (20mg/mL) and EPINEPHRINE HCl 1:200,000, 10 ml Single Dose Vial, Rx only, Compounded drug by Medivant Healthcare, 158 S Kyrene Rd, Chandler, AZ 85226, NDC 81483-0038-0, UPC 3 81483 00380 2
Manufacturer(s)
TAILSTORM HEALTH INC
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →